skip to content

HIV/AIDS Glossary

Pediatric AIDS Clinical Trials Group 076 (PACTG 076)

A federally funded study that determined that the risk of mother-to-child transmission (MTCT) of HIV could be reduced by nearly 70% if the antiretroviral (ARV) drug zidovudine was given to a woman during pregnancy and labor and delivery and to the newborn. The Pediatric AIDS Clinical Trials Group 076 (PACTG 076) study contributed greatly to preventing MTCT of HIV.

Search the Glossary

What's this?

Print

AIDSinfo Glossary App

Download Glossary